retatrutide 3 receptors Diagram showing the mechanism of action of Retatrutide | GLP-1R/GIPR/GCGR ligand |

M., Rosenstock, J., Tran, M

Development of an instrument to assess expectations of and preference for an insulin injection pen compared with the vial and syringe

Poor sleep increases ghrelin (hunger hormone) and decreases leptin (satiety hormone), making weight loss more difficult

Biomed Res Int (2015) 2015:850902.10.1155/2015/850902 188 CatoireMKerstenS

The Novo Nordisk Foundation Center for Protein Research is supported financially by the Novo Nordisk Foundation (grant number NNF14CC0001)

Together with Ryan Livingston, we created a piece looking back at the 1-year implications of the GLP-1 antagonist for CKD and T2D, speaking with key experts from Cleveland Clinic and the American Heart Association, along with Holly Kramer from Loyola Medicine, Editor-in-Chief at Advances in Kidney Disease and Health (AKDH)